These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 22103936

  • 1. Toxicity testing: the need for new maps for the future.
    Balls M.
    Altern Lab Anim; 2011 Oct; 39(5):417-8. PubMed ID: 22103936
    [No Abstract] [Full Text] [Related]

  • 2. Animal testing: more than a cosmetic change.
    Abbott A.
    Nature; 2005 Nov 10; 438(7065):144-6. PubMed ID: 16281001
    [No Abstract] [Full Text] [Related]

  • 3. Testing on animals. Editorial.
    von Aulock S.
    ALTEX; 2013 Nov 10; 30(2):U2. PubMed ID: 23805430
    [No Abstract] [Full Text] [Related]

  • 4. Novel strategies for toxicological risk assessments.
    Roy A, Akbarsha MA.
    ALTEX; 2014 Nov 10; 31(1):91-3. PubMed ID: 24448760
    [No Abstract] [Full Text] [Related]

  • 5. Developing alternatives to systemic toxicity testing approaches.
    von Aulock S.
    ALTEX; 2012 Nov 10; 29(1):1. PubMed ID: 22408846
    [No Abstract] [Full Text] [Related]

  • 6. Novel technologies and an overall strategy to allow hazard assessment and risk prediction of chemicals, cosmetics, and drugs with animal-free methods.
    Leist M, Lidbury BA, Yang C, Hayden PJ, Kelm JM, Ringeissen S, Detroyer A, Meunier JR, Rathman JF, Jackson GR, Stolper G, Hasiwa N.
    ALTEX; 2012 Nov 10; 29(4):373-88. PubMed ID: 23138508
    [Abstract] [Full Text] [Related]

  • 7. A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing.
    Basketter DA, Clewell H, Kimber I, Rossi A, Blaauboer B, Burrier R, Daneshian M, Eskes C, Goldberg A, Hasiwa N, Hoffmann S, Jaworska J, Knudsen TB, Landsiedel R, Leist M, Locke P, Maxwell G, McKim J, McVey EA, Ouédraogo G, Patlewicz G, Pelkonen O, Roggen E, Rovida C, Ruhdel I, Schwarz M, Schepky A, Schoeters G, Skinner N, Trentz K, Turner M, Vanparys P, Yager J, Zurlo J, Hartung T.
    ALTEX; 2012 Nov 10; 29(1):3-91. PubMed ID: 22307314
    [Abstract] [Full Text] [Related]

  • 8. Towards an integrated in vitro strategy for repeated dose toxicity testing.
    Vanhaecke T, Pauwels M, Vinken M, Ceelen L, Rogiers V.
    Arch Toxicol; 2011 May 10; 85(5):365-6. PubMed ID: 21512801
    [No Abstract] [Full Text] [Related]

  • 9. Is the replacement strategy, as it exists today in the EU for cosmetics, the way forward ?
    Rogiers V.
    Arch Toxicol; 2011 May 10; 85(5):363-4. PubMed ID: 21528384
    [No Abstract] [Full Text] [Related]

  • 10. Test guidelines for assessment of skin compatibility of cosmetic finished products in man. Task Force of COLIPA.
    Walker AP, Basketter DA, Baverel M, Diembeck W, Matthies W, Mougin D, Paye M, Röthlisberger R, Dupuis J.
    Food Chem Toxicol; 1996 Jul 10; 34(7):651-60. PubMed ID: 8761358
    [No Abstract] [Full Text] [Related]

  • 11. Food for thought ... on alternative methods for cosmetics safety testing.
    Hartung T.
    ALTEX; 2008 Jul 10; 25(3):147-62. PubMed ID: 18841313
    [No Abstract] [Full Text] [Related]

  • 12. Strategies to replace in vivo acute systemic toxicity testing. The report and recommendations of ECVAM Workshop 50.
    Gennari A, van den Berghe C, Casati S, Castell J, Clemedson C, Coecke S, Colombo A, Curren R, Dal Negro G, Goldberg A, Gosmore C, Hartung T, Langezaal I, Lessigiarska I, Maas W, Mangelsdorf I, Parchment R, Prieto P, Sintes JR, Ryan M, Schmuck G, Stitzel K, Stokes W, Vericat JA, Gribaldo L, ECVAM Workshop 50.
    Altern Lab Anim; 2004 Oct 10; 32(4):437-59. PubMed ID: 15651930
    [No Abstract] [Full Text] [Related]

  • 13. An expert consortium review of the EC-commissioned report "alternative (Non-Animal) methods for cosmetics testing: current status and future prospects - 2010".
    Hartung T, Blaauboer BJ, Bosgra S, Carney E, Coenen J, Conolly RB, Corsini E, Green S, Faustman EM, Gaspari A, Hayashi M, Wallace Hayes A, Hengstler JG, Knudsen LE, Knudsen TB, McKim JM, Pfaller W, Roggen EL.
    ALTEX; 2011 Oct 10; 28(3):183-209. PubMed ID: 21993956
    [Abstract] [Full Text] [Related]

  • 14. International STakeholder NETwork (ISTNET) for creating a developmental neurotoxicity testing (DNT) roadmap for regulatory purposes.
    Crofton K, Fritsche E, Ylikomi T, Bal-Price A.
    ALTEX; 2014 Oct 10; 31(2):223-4. PubMed ID: 24794006
    [No Abstract] [Full Text] [Related]

  • 15. Is there a need in regulatory toxicity testing for evaluating chemicals at doses eliciting general toxicity?
    Chahoud I, Grote K.
    Toxicology; 2016 Jul 01; 363-364():46-7. PubMed ID: 27430607
    [No Abstract] [Full Text] [Related]

  • 16. Evidence-Based Toxicology Collaboration (EBTC). Editorial.
    von Aulock S.
    ALTEX; 2013 Jul 01; 30(1):1. PubMed ID: 23451363
    [No Abstract] [Full Text] [Related]

  • 17. A less toxic solution.
    Nature; 2005 Nov 10; 438(7065):129-30. PubMed ID: 16280988
    [No Abstract] [Full Text] [Related]

  • 18. Regulatory toxicology in the twenty-first century: challenges, perspectives and possible solutions.
    Tralau T, Oelgeschläger M, Gürtler R, Heinemeyer G, Herzler M, Höfer T, Itter H, Kuhl T, Lange N, Lorenz N, Müller-Graf C, Pabel U, Pirow R, Ritz V, Schafft H, Schneider H, Schulz T, Schumacher D, Zellmer S, Fleur-Böl G, Greiner M, Lahrssen-Wiederholt M, Lampen A, Luch A, Schönfelder G, Solecki R, Wittkowski R, Hensel A.
    Arch Toxicol; 2015 Jun 10; 89(6):823-50. PubMed ID: 25820917
    [Abstract] [Full Text] [Related]

  • 19. Food for thought ... why no new in vitro tests will be done for REACH by registrants.
    Rovida C.
    ALTEX; 2010 Jun 10; 27(3):175-83. PubMed ID: 21113560
    [No Abstract] [Full Text] [Related]

  • 20. Alternative in vitro methods to characterize the role of Endocrine Active Substances (EASs) in hormone-targeted tissues.
    Rovida C, De Angelis I, Lorenzetti S.
    ALTEX; 2013 Jun 10; 30(2):253-5. PubMed ID: 23665809
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.